FNY Investment Advisers’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
19,533
+9,997
| +105% | +$113K | 0.09% | 200 |
|
|
2025
Q1 | $96K | Sell |
9,536
-1,980
| -17% | -$19.9K | 0.06% | 223 |
|
|
2024
Q4 | $136K | Sell |
11,516
-10
| -0.1% | -$118 | 0.07% | 235 |
|
|
2024
Q3 | $133K | Buy |
11,526
+1,306
| +13% | +$15.1K | 0.06% | 206 |
|
|
2024
Q2 | $108K | Buy |
10,220
+2,720
| +36% | +$28.7K | 0.07% | 169 |
|
|
2024
Q1 | $79 | Buy |
7,500
+4,500
| +150% | +$47 | 0.05% | 206 |
|
|
2023
Q4 | $33K | Buy |
+3,000
| New | +$33K | 0.04% | 219 |
|